NASDAQ:NXTM - NxStage Medical Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NxStage Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $30.00 0.00 (0.00 %) (As of 02/21/2019) Add Compare Today's Range$29.98Now: $30.00▼$30.0050-Day Range$30.00MA: $30.00▼$30.0052-Week Range$23.17Now: $30.00▼$30.00Volume2.61 million shsAverage Volume1.51 million shsMarket Capitalization$2.00 billionP/E RatioN/ADividend YieldN/ABeta0.25 ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NxStage Medical, Inc, a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:NXTM Previous Symbol CUSIP67072V10 CIK1333170 Webhttp://www.nxstage.com/ Phone978-687-4700Debt Debt-to-Equity RatioN/A Current Ratio3.60 Quick Ratio2.69Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$393.94 million Price / Sales5.08 Cash Flow$0.29 per share Price / Cash Flow103.07 Book Value$3.22 per share Price / Book9.32Profitability EPS (Most Recent Fiscal Year)($0.22) Net Income$-14,470,000.00 Net Margins-1.29% Return on Equity-2.50% Return on Assets-1.60%Miscellaneous EmployeesN/A Outstanding Shares66,680,000Market Cap$2.00 billion Next Earnings DateN/A OptionableOptionable Receive NXTM News and Ratings via Email Sign-up to receive the latest news and ratings for NXTM and its competitors with MarketBeat's FREE daily newsletter. NxStage Medical (NASDAQ:NXTM) Frequently Asked Questions What is NxStage Medical's stock symbol? NxStage Medical trades on the NASDAQ under the ticker symbol "NXTM." How were NxStage Medical's earnings last quarter? NxStage Medical, Inc. (NASDAQ:NXTM) issued its quarterly earnings data on Monday, August, 7th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.00. The medical device company had revenue of $92.20 million for the quarter, compared to analyst estimates of $96.47 million. NxStage Medical had a negative return on equity of 2.50% and a negative net margin of 1.29%. The business's quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.03) earnings per share. View NxStage Medical's Earnings History. Has NxStage Medical been receiving favorable news coverage? Press coverage about NXTM stock has trended extremely negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. NxStage Medical earned a coverage optimism score of -4.3 on InfoTrie's scale. They also assigned news coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for NxStage Medical. Who are some of NxStage Medical's key competitors? Some companies that are related to NxStage Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR) and Steris (STE). What other stocks do shareholders of NxStage Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other NxStage Medical investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Och-Ziff Capital Management Group (OZM), Gran Tierra Energy (GTE) and ALJ Regional (ALJJ). Who are NxStage Medical's key executives? NxStage Medical's management team includes the folowing people: Mr. Jeffrey H. Burbank, Founder, CEO & Director (Age 56)Mr. Joseph E. Turk Jr., Pres (Age 51)Mr. Matthew W. Towse, Sr. VP, CFO & Treasurer (Age 56)Ms. Winifred L. Swan, Sr. VP, Gen. Counsel & Sec. (Age 55)Dr. Allan J. Collins, Head of Scientific Advisory Board & Chief Medical Officer What is NxStage Medical's stock price today? One share of NXTM stock can currently be purchased for approximately $30.00. How big of a company is NxStage Medical? NxStage Medical has a market capitalization of $2.00 billion and generates $393.94 million in revenue each year. The medical device company earns $-14,470,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. View Additional Information About NxStage Medical. What is NxStage Medical's official website? The official website for NxStage Medical is http://www.nxstage.com/. How can I contact NxStage Medical? NxStage Medical's mailing address is 350 MERRIMACK STREET, LAWRENCE MA, 01843. The medical device company can be reached via phone at 978-687-4700 or via email at [email protected] MarketBeat Community Rating for NxStage Medical (NASDAQ NXTM)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 374 (Vote Outperform)Underperform Votes: 331 (Vote Underperform)Total Votes: 705MarketBeat's community ratings are surveys of what our community members think about NxStage Medical and other stocks. Vote "Outperform" if you believe NXTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXTM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/29/2020 by MarketBeat.com StaffFeatured Article: How does quantitative easing work?